Medically reviewed by Drugs.com. Last updated on Jan 12, 2021.
Recommended Dosage for Wilms Tumor
The recommended dose of COSMEGEN, as part of a multi-agent combination chemotherapy regimen, is 45 mcg/kg intravenously once every 3 to 6 weeks for up to 26 weeks.
Recommended Dosage for Rhabdomyosarcoma
The recommended dose of COSMEGEN, as part of a multi-agent combination chemotherapy regimen, is 15 mcg/kg intravenously once daily for 5 days every 3 to 9 weeks for up to 112 weeks.
Recommended Dosage for Ewing Sarcoma
The recommended dose of COSMEGEN, as part of a multi-agent combination chemotherapy regimen, is 1250 mcg/m 2 intravenously once every 3 weeks for 51 weeks.
Recommended Dosage for Metastatic Nonseminomatous Testicular Cancer
The recommended dose of COSEMGEN, as part of a cisplatin-based, multi-agent combination chemotherapy regimen, is 1000 mcg/m 2 intravenously once every 3 weeks for 12 weeks.
Recommended Dosage for Gestational Trophoblastic Neoplasia
The recommended dose of COSEMEGEN for nonmetastatic and low-risk metastatic disease is 12 mcg/kg intravenously daily for five days as a single agent.
The recommended dose of COSEMEGEN, as part of a multi-agent combination chemotherapy regimen, for high-risk metastatic disease is 500 mcg intravenously on Days 1 and 2 every 2 weeks for up to 8 weeks.
Recommended Dosage for Regional Perfusion in Locally Recurrent and Locoregional Solid Malignancies
The recommended dose of COSMEGEN, in combination with melphalan, is 50 mcg/kg once for lower extremity or pelvis.
The recommended dose of COSMEGEN, in combination with melphalan, is 35 mcg/kg once for upper extremity.
Calculate the dose for obese or edematous patients based on ideal body weight.
Preparation and Administration
- COSMEGEN is a cytotoxic drug. Follow applicable special handling and disposal procedures. 1
- Visually inspect the vials for particulate matter and discoloration, whenever solution and container permit.
- Reconstitute each vial by adding 1.1 mL of Sterile Water for Injection without preservative using aseptic techniques.
- The reconstituted product should be a clear, gold-colored solution at a concentration of 500 mcg/mL.
- Further dilute the reconstituted product with 5% Dextrose Injection or 0.9% Sodium Chloride Injection to yield concentrations greater than 10 mcg/mL.
- Store at room temperature for no more than 4 hours from reconstitution to completion of injection or infusion. Discard after 4 hours.
- COSMEGEN does not contain a preservative. Discard any unused portions.
- Administer the diluted reconstituted product intravenously over 10 to 15 minutes.
- Do not use in-line filters with a cellulose ester membrane.
Management of Extravasation
- Discontinue COSMEGEN for burning or stinging sensation or other evidence indicating perivenous infiltration or extravasation.
- Manage confirmed or suspected extravasation as follows:
- Terminate the injection or infusion immediately and restart in another vein.
- Intermittent application of ice to the site for 15 minutes 4 times daily for 3 days [see Warnings and Precautions ( 5.3)].
More about Cosmegen (dactinomycin)
- Side effects
- Drug interactions
- During pregnancy or Breastfeeding
- Pricing & coupons
- Generic availability
- En español
- Drug class: antibiotics/antineoplastics
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.